Download Citation
Article Source:
Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613
Guardado Rivas MO,
Stuart SD,
Thach D,
Dahan M,
Shorr R,
et al.
(2022)
Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613.
PLOS ONE 17(6): e0269620.
https://doi.org/10.1371/journal.pone.0269620